Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Fernando Espí Forcén

11 papers in the library · 9 citations · publishing 2022-2026

Papers

Ketamine for refractory depression: Save the best for last?

Journal of psychopharmacology (Oxford, England) January 1, 2025 Kabir Nigam, Franklin King, Fernando Espí Forcén 4 citations

Ketamine is non-inferior to electroconvulsive therapy (ECT) for depression and is better tolerated than many second-line augmentation strategies. Currently viewed as a third-line agent for treatment-refractory depression, the available data suggest ketamine carries a low side-effect burden. Given the relationship between treatment outcomes and duration of untreated illness, the authors argue psychiatry should evaluate ketamine as a second-line augmentation strategy for refractory depression.

From Entheogens to Evangelicalism: Spiritual Practices Among Hispanic/Latin Americans

Psychiatric Annals December 1, 2023 Fernando Espí Forcén 3 citations

Spirituality among Hispanic and Latinx people takes many forms. While Catholicism has been dominant for centuries, Native American and African spiritual traditions have experienced a revival in recent decades. At the same time, Evangelical Christianity is rapidly growing in popularity across Latin America, reflecting the influence of the United States. To properly study these spiritual practices, researchers must understand the historical changes that shaped these religions and the context in which they became established in the region.

Advancing ketamine in the treatment hierarchy for refractory depression.

The British journal of psychiatry : the journal of mental science October 25, 2024 Kabir Nigam, Franklin King, Fernando Espí Forcén 2 citations

Ketamine appears highly effective for refractory depression, with fewer side effects and better tolerability than many other augmentation strategies. Evidence on mediators of psychiatric treatment outcomes suggests that using ketamine earlier in the course of treatment could improve patient outcomes.

Investing in Group Psychedelic Therapy for Latinx Immigrants.

Journal of immigrant and minority health June 9, 2025 Juliana Zambrano, Fernando Espí Forcén, Jose Hidalgo et al.

Psychedelic-assisted therapies show promise for depression and PTSD, but their application has largely excluded marginalized groups such as Latinx immigrants, who face mental health challenges at rates similar to white populations yet have lower treatment engagement due to cultural stigma, language barriers, and limited access to culturally competent care. This paper argues for group-based, culturally adapted models of psychedelic-assisted therapy tailored to Latinx immigrants, emphasizing community healing, collective therapeutic processes, and the incorporation of cultural traditions. Group psychedelic therapy may enhance social connections, reduce isolation, and increase accessibility while addressing unique immigrant stressors. Rigorous research and culturally competent care models are needed to reduce mental health disparities.

Imágenes psicodélicas en The Holy Mountain (1973). Un análisis e interpretación del clásico de culto de Alejandro Jodorowsky

Imafronte April 11, 2025 Fernando Espí Forcén

Alejandro Jodorowsky's 1973 film The Holy Mountain has gained cult status, recently amplified by the psychedelic renaissance. The article reviews, analyzes, and interprets the film's symbolism, which incorporates countercultural ideas, Eastern philosophy, alchemy, astrology, and tarot. Rich in psychedelic imagery from the psychoanalytic tradition, the film explores themes central to psychedelic visual culture: descriptions of psychedelic substances and ceremonies, philosophies of the psychedelic counterculture, deconstruction of societal norms, and trauma exploration and healing from psychedelic experiences.

A Psilocybin Experience Gone Wrong: The Importance of Psychedelic Assisted Psychotherapy

Journal of Psychoactive Drugs January 7, 2025 Fernando Espí Forcén

A patient who used psilocybin without psychedelic-assisted psychotherapy required inpatient psychiatric admission. The case highlights the importance of taking psilocybin in controlled clinical settings. The authors discuss how psychedelic-assisted psychotherapy could have changed the outcome and the role of experiential learning for potential prescribers.

Pharmacotherapy and Ketamine Assisted Psychotherapy for Treatment-Resistant Depression: A Patient With Lifelong Self-Doubt and Self-Criticism.

The Journal of Clinical Psychiatry April 5, 2023 Albert Yeung, Guy Sapirstein, Laura D Crain et al.

Treatment-resistant depression (TRD) is most commonly defined by at least two prior treatment failures with adequate dose and duration, though consensus is lacking. A clinical case illustrates a patient with long-standing depression and inadequate treatment response, where persistent self-criticism appears to drive unrelenting symptoms, intense anger, self-doubt, and self-disapproval. The article explores potential causes of self-criticism, its impact on depression and help-seeking, and plausible treatment approaches.

Ketamine-assisted meaning-centered psychotherapy for a patient with severe suicidal behavior

Palliative and Supportive Care April 1, 2023 Fernando Espí Forcén, Laura Marengo, Maya Behn

A patient with recurrent, severe depression and suicidal ideation improved after receiving meaning-centered psychotherapy combined with ketamine. His scores on a suicide assessment tool improved significantly with this combination. Ketamine is generally well tolerated and can enhance outcomes in patients undergoing meaning-centered psychotherapy.

Ketamine With Psychotherapy for the Treatment of Depression

Psychiatric Annals September 1, 2022 Fernando Espí Forcén, Maren Nyer

Ketamine is the only prescribable psychedelic medicine in the United States and a promising treatment for depression. Most ketamine clinics currently administer ketamine without psychotherapy. This article reviews recent literature on combining ketamine with psychotherapy for psychiatric disorders, opening discussion on whether combined treatment offers benefits over ketamine alone.